Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Treatment Outcome  [Clear All Filters]
2018
Arora S, Matsushita K, Qamar A, R Stacey B. "Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: The atherosclerosis risk in communities surveillance study." Catheter Cardiovasc Interv. 2018;91(2):253-259.
Arora S, Stouffer GA, Kucharska-Newton AMaria, et al. "Fifteen-Year Trends in Management and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000-2014." J Am Heart Assoc. 2018;7(19):e010203.
Zhou Q, Cai J. "Outcome-dependent sampling with interval-censored failure time data." Biometrics. 2018;74(1):58-67.
Chang PP, Wruck LM, Shahar E, et al. "Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance." Circulation. 2018;138(1):12-24.
2017
Gregson JM, Freitag DF, Surendran P, et al. "Genetic invalidation of Lp-PLA as a therapeutic target: Large-scale study of five functional Lp-PLA-lowering alleles." Eur J Prev Cardiol. 2017;24(5):492-504.
Rawlings AM, Sharrett ARichey, Mosley TH, Ballew SH, Deal JA. "Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline." Diabetes Care. 2017;40(7):879-886.
2016
Roberts JD, Dewland TA, Glidden DV, et al. "Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation." Am Heart J. 2016;175:9-17.
Postmus I, Warren HR, Trompet S, et al. "Meta-analysis of genome-wide association studies of HDL cholesterol response to statins." J Med Genet. 2016;53(12):835-845.
2015
Bis JC, Sitlani C, Irvin R, et al. "Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium." PLoS One. 2015;10(10):e0140496.
Shah AM, Claggett B, Sweitzer NK, et al. "Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone." Circulation. 2015;132(5):402-14.
Hardy ST, Loehr LR, Butler KR, et al. "Reducing the Blood Pressure-Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control." J Am Heart Assoc. 2015;4(10):e002276.
2014
Folsom AR, Roetker NS, Rosamond WD, Heckbert SR, Basu S, Cushman M. "Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study." J Thromb Haemost. 2014;12(9):1455-60.
2013
Shinohara RT, Narayan AK, Hong K, et al. "Estimating parsimonious models of longitudinal causal effects using regressions on propensity scores." Stat Med. 2013;32(22):3829-37.
O'Brien EC, Rose KM, Suchindran CM, et al. "Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction." Heart. 2013;99(11):767-73.
2008
Foraker RE, Rose KM, McGinn AP, et al. "Neighborhood income, health insurance, and prehospital delay for myocardial infarction: the atherosclerosis risk in communities study." Arch Intern Med. 2008;168(17):1874-9.
2005
Watkins S, Thiemann D, Coresh J, Powe N, Folsom AR, Rosamond W. "Fourteen-year (1987 to 2000) trends in the attack rates of, therapy for, and mortality from non-ST-elevation acute coronary syndromes in four United States communities." Am J Cardiol. 2005;96(10):1349-55.
1999
Rosamond W, Broda G, Kawalec E, et al. "Comparison of medical care and survival of hospitalized patients with acute myocardial infarction in Poland and the United States." Am J Cardiol. 1999;83(8):1180-5.
1998
Rywik SL, Davis CE, Pajak A, et al. "Poland and U.S. collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment, and control of hypertension in the Pol-MONICA Project and the U.S. Atherosclerosis Risk in Communities Study." Ann Epidemiol. 1998;8(1):3-13.